This position reports directly to Dr. Witkowski and is responsible for developing, executing and analyzing data from research projects aimed at understanding metabolic dependencies impacting the biology and function of B-ALL resistance to conventional and immune-based therapies (e.g., CD19-directed chimeric antigen receptor therapy). The position is an opportunity for a bright, creative and enthusiastic individual to advance their career by performing impactful, cutting-edge biomedical research in an exciting field of study. Individuals who are about to graduate or have recently graduated from their doctoral training are preferred. This position is expected to work independently under the guidance of the principal investigator. Projects will involve work with research animals and extensive development and use of cutting-edge flow cytometry, molecular biology and cell biology assays on leukemia and adoptive T cell therapeutics (e.g., CAR-T). To fulfill job requirements, candidates must receive training and adhere to institutional standards of best practice in: animal care and handling, radiation and chemical safety, laboratory safety and other areas as determined by the institution and/or PI. The Witkowski Lab is based in the Department of Pediatrics in the Hematology/Oncology/Bone Marrow Transplant Laboratories, and has secondary appointment in the Department of Medicine in the Division of Hematology, led by Principal Investigator, Dr. Matt Witkowski. The lab is part of a richly collaborative interdisciplinary group of basic scientists and clinicians from immunology, hematology and molecular biology backgrounds with significant resources and expertise in understanding normal B cell progenitor and acute lymphoblastic leukemia (B-ALL) development.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree
Number of Employees
11-50 employees